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Abstract
New approaches to treat bacterial infections are badly needed to address the increasing problem
of antibiotic-resistance. This study explores phosphonium-functionalized block copolymer
micelles as intrinsically antibacterial polymer assemblies. Phosphonium cations with varying
alkyl lengths were conjugated to the terminus of a poly(ethylene oxide)-polycaprolactone block
copolymer and the phosphonium-functionalized block copolymers were self-assembled to form
micelles in aqueous solution. The size, morphology, and z-potential of the assemblies were
studied and their abilities to kill Escherichia coli and Staphylococcus aureus were evaluated. It
was found that the minimum bactericidal concentration depended on the phosphonium alkyl
chain length and different trends were observed for Gram-negative and Gram-positive bacteria.
The most active assemblies exhibited no hemolysis of red blood cells above the bactericidal
1

concentrations, indicating that they can selectively disrupt the membranes of bacteria.
Furthermore, it was possible to encapsulate and release the antibiotic tetracycline using the
assemblies, providing a potential multi-mechanistic approach to bacterial killing.
Keywords
Phosphonium, antibacterial, micelles, antibiotic, self-assembly

Introduction
Polymeric nanocarriers, self-assembled nanoscopic materials with domains of different
hydrophilicity, have been extensively investigated due to their abilities to encapsulate
biomedically relevant cargo and to provide a chemically tunable platform.1–4 Common
nanocarrier morphologies are spherical micelles5, cylindrical micelles,6,7 bilayer structures (e.g.
vesicles)8 and in some circumstances more complex architectures that can be obtained using
unconventional polymers or intermolecular interactions.9 Amphiphilic block copolymers are
often the structural components of polymeric nanocarriers, due to the control they provide over
the morphology and the well-established chemistry used to synthesize and functionalize them.
By encapsulating hydrophobic compounds into the hydrophobic domains of nanomaterials, these
water-insoluble molecules can be dispersed in aqueous solutions.4,10,11 Block copolymer
nanocarriers have been and continue to be investigated for the delivery of a large variety of
compounds including small molecule drugs, therapeutic nucleic acids, imaging contrast agents,
and antibacterial compounds.1,4,12
An increase in the occurrence of pernicious antibiotic resistant bacteria is currently
motivating a search for novel ways of combating bacterial infections. The World Health
Organization warns that in order to avoid a return to the “pre-antibiotic” age, researchers and
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health professionals need to employ new and varied antibiotic treatments of bacterial
infections.13 The ability to incorporate hydrophobic antibacterial compounds into aqueous
dispersible nanocarriers allows for increased availability of the drugs at the site of infection.14
The use of nanocarriers has allowed researchers to utilize traditional antibacterial compounds
with improved efficacy. For example, intracellular bacterial infections are often resistant to
antibacterial treatment due to the localization of the bacteria in the eukaryotic cells. Maya and
coworkers were able to target intracellular Staphylococcus aureus (S. aureus) by encapsulating
tetracycline in chitosan nanoparticles.15 Li et al. demonstrated the encapsulation of antibacterial
agents into polymer vesicles that enzymatically degraded in the presence of target bacteria to
deliver the antibacterial cargo.16 Furthermore, Liu and coworkers have recently demonstrated the
ability of triclosan-loaded micelles to penetrate into biofilms and to kill the S. aureus residing in
the biofilms with greater efficacy than free triclosan.17 There are many other examples that
demonstrate the increase in desirable properties that can be achieved by loading antibacterial
small molecules into nanocarrier systems.12,18,19 This approach may also allow for the use new
poorly water-soluble antibacterial compounds in the combat of antibacterial resistance.
Far fewer examples exist of nanocarriers with inherently antibacterial units. This is
somewhat surprising given the extensive research that has been performed on incorporating
functionality into nanocarrier design.2,20 The incorporation of silver nanoparticles21–23 and/or
polymers such as chitosan24,25 or other polyammonium cations,26–29, have been explored as an
approach for imparting antibacterial activity to nanocarriers. Previously unexplored is the use of
phosphonium cations to impart antibacterial activity to polymeric nanocarriers. Phosphonium
cations, like ammonium cations, are thought to interact with the negatively charged structural
biopolymers and phospholipids on the outer surfaces of bacteria cell walls, leading to penetration
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of the cell wall, ultimately resulting in cell death.29–31 Gram-positive bacteria such as S. aureus
have teichoic acid polymers on the cell wall that confer a negative charge and Gram-negative
bacteria such as Escherichia coli (E. coli) have lipopolyssacharides that are responsible for the
negative charge of the cell surface. Previous research has demonstrated that phosphonium salts
as well as their corresponding polymers exhibit improved antibacterial efficacy compared to
analogous ammonium compounds.32–34 This can arise from the differences in charge distribution
between the larger phosphonium cation and smaller ammonium cation. In this context, we
recently demonstrated the efficacy of surfaces and semi-interpenetrating networks containing
phosphonium cations against Gram-positive and Gram-negative bacteria.35,36
Here we explore the synthesis and self-assembly of phosphonium end-capped poly(ethylene
oxide)-block-polycaprolactone (PEO-b-PCL) copolymers. To the best of our knowledge, this
represents the first example of phosphonium-functionalized block copolymer assemblies in
aqueous solution. We also demonstrate the antibacterial properties of the assemblies against S.
aureus and E. coli. Furthermore, it is shown that the antibiotic tetracycline can be incorporated
into the micelles, potentially providing orthogonal modes of action, where the traditional
antibiotic targets specific pathways in bacteria while the phosphonium cation provides
membrane disruption (Figure 1). While work exists demonstrating the benefit of combining
antibacterial nanoparticles with traditional antibacterial small molecules25,37 the deliberate
encapsulation of a traditional antibacterial agent within an intrinsically antibacterial polymeric
nanocarrier has not been reported.
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Figure 1. Schematic illustrating a phosphonium-functionalized micelle loaded with antibiotic.
Experimental
General procedures and materials
Methoxy and azide-terminated block copolymers (MeO-BCP and N3-BCP respectively) were
prepared as previously reported38 and the characterization data for the specific batches used in
the current work are included in the supporting information. Briefly, they were prepared by ringopening polymerizations of freshly distilled ε-caprolactone in dry toluene initiated by PEO
monomethyl ether (MeO-PEO) or PEO monoazide (N3-PEO). Methanesulfonic acid was used
as a catalyst, and the product was obtained by precipitation into cold hexanes. Solvents were
dried using an MBraun Solvent Purification System. Dried solvent was collected under vacuum
in a flame-dried Straus flask and stored over 4Å molecular sieves. Purified water was obtained
using a BarnsteadTM EASYPure® II ultra pure water system (ThermoFisher Scientific). Nuclear
Magnetic Resonance (NMR) spectroscopy was conducted on a Varian INOVA 400 MHz
spectrometer (Agilent Technologies, Santa Clara, CA; 1H 400 MHz, 31P{1H} 162 MHz, 13C{1H}
100 MHz) unless otherwise noted. All 1H NMR spectra were referenced relative to the residual
solvent peak (CHCl3; 1H δ = 7.27). The chemical shifts for 31P{1H} NMR spectroscopy were
referenced using an external standard (85% H3PO4; δP = 0). All 13C{1H} NMR spectra were
referenced relative to the residual solvent peak (CDCl3; 13C δ = 77.0). Infrared (IR) spectra were
obtained using a Bruker Tensor 27 spectrometer using attenuated total internal reflectance mode
5

(ATR) on a ZnSe crystal. High Resolution Mass spectrometry (HRMS) were obtained on a
Finnigan MAT 8400 mass spectrometer using electron impact ionization. Dynamic light
scattering (DLS) and z-potential measurements were performed on a Zetsizer Nano ZS from
Malvern Instruments equipped with a 633 nm laser. A polymer concentration of ~0.1 mg/mL of
polymer were used in DLS measurements. Ultraviolet-visible (UV-vis) spectroscopy was
performed using a Varian Cary 300 Bio UV-visible spectrophotometer. The size exclusion
chromatography (SEC) instrument was equipped with a Viscotek GPC Max VE2001 solvent
module (Malvern Instruments Ltd., Malvern, UK). Samples were analyzed using the Viscotek
VE3580 RI detector operating at 30 °C. The separation technique employed two Agilent
Polypore (300 × 7.5 mm) columns connected in series and to a Polypore guard column (50 × 7.5
mm) (Agilent Technologies). Samples were dissolved in tetrahydrofuran (THF) (glass distilled
grade) at a concentration of approximately 5 mg/mL, filtered through 0.22 µm syringe filters, and
then injected using a 100 µL loop. The THF eluent was filtered and eluted at 1 mL/min for a total
of 30 min. The instrument was calibrated with PEO standards. Dialysis was performed using
Spectra/Por® 6 pre-wetted dialysis tubing (Spectrum Laboratories Inc.).

Synthesis of tri-n-butyl(1-pentynyl)phosphonium chloride (Bu3P-yne)
Tributylphosphine (5.00 g, 24.5 mmol, 1.0 equiv.) was dissolved in dry CH3CN in a pressure
tube inside a glovebox. 5-Chloro-1-pentyne (2.80 g, 27.3 mmol, 1.1 equiv.) was then added
dropwise to the stirring phosphine solution. The pressure tube was sealed and then heated at 100
°C. The reaction was monitored by 31P{1H} NMR spectroscopy. Upon exhaustion of the tributyl
phosphine the volatile components were removed in vacuo. The crude product was dissolved in
CH2Cl2 and precipitated into a rapidly stirring solution of cold hexanes (0 °C) to afford an off-
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white powder. The product was recovered by vacuum filtration. Yield = 6.31 g, 84%. 1H NMR
(400 MHz, CDCl3): δ = 2.70 – 2.68 (m, 2H), 2.53 – 2.42 (m, 8H), 2.05 (t, 4J(H,H) = 2.73 Hz,
1H), 1.90 – 1.79 (m, 2H), 1.61 – 1.47 (m, 12H), 0.97 (t, 3J(H,H) = 7.23 Hz, 9H). 13C{1H}
(100.52 MHz, CDCl3): δ = 82.0, 70.5, 23.9 (d, 3J(P,C) = 15.3 Hz), 23.7 (d, 2J(P,C) = 5.3 Hz),
21.0 (d, 2J(P,C) = 3.8 Hz), 19.4 (d, 3J(P,C) = 16.8 Hz), 19.0 (d, 1J(P,C) = 47.5 Hz), 18.2 (d,
1

J(P,C) = 49.0 Hz), 13.4. 31P{1H} NMR (161.82 MHz, CDCl3): δ = 34. ATR-IR: 2105 cm-1 (w,

C≡C-H), 2960 cm-1 (s, CH). HRMS calculated for C17H34P [M]+: 269.2398; Found: 269.2400.

Synthesis of triethyl(1-pentynyl)phosphonium chloride (Et3P-yne)
The same procedure described above for the synthesis of Bu3P-yne was used except that
triethylphosphine was used as the starting material. The product was obtained as a light brown
powder. Yield = 80%. 1H NMR (400 MHz, CDCl3): δ = 2.62 – 2.47 (m, 8H), 2.41 (ddt, 3J(H,H)
= 3.6 Hz, 4J(H,H) = 2.7 Hz, 4J(P,H) = 0.8 Hz, 2H), 2.02 (t, 4J(H,H) = 2.7 Hz, 1H), 1.87 – 1.77
(m, 2H), 1.28 (dt, 3J(H,H) = 7.6 Hz, 3J(P,H) = 18.0 Hz, 9H). 13C{1H} (100.52 MHz, CDCl3): δ =
82.1, 70.9, 21.0 (d, 2J(P,C) = 3.7 Hz), 19.6 (d, 3J(P,C) = 16.5 Hz), 17.1 (d, 1J(P,C) = 48.6 Hz),
12.5 (d, 1J(P,C) = 48.7 Hz), 6.2 (d, 2J(P,C) = 5.5 Hz). 31P{1H} NMR (161.82 MHz, CDCl3): δ =
39. ATR-IR: 2105 cm-1 (w, C≡C-H), 2960 cm-1 (s, CH). HRMS calculated for C11H21P [M]+:
184.1381; Found: 184.1379.

Synthesis of tri-n-octyl(1-pentynyl)phosphonium chloride (Oct3P-yne)
Tri-n-octylphosphine (1.00 g, 2.70 mmol, 1.0 equiv.) was dissolved in dry dioxane in a pressure
tube inside a glovebox. 5 mg of NaI was added to the reaction mixture. 5-Chloro-1-pentyne
(0.300 g, 2.92 mmol, 1.1 equiv.) was then added dropwise to the stirring phosphine solution. The
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pressure tube was sealed and then heated at 100 °C. The reaction was monitored by 31P{1H}
NMR spectroscopy. At approximately 50% conversion of the starting phosphine, the excess
phosphine, 5-chloropentyne and solvent were removed in vacuo. The resulting colourless oil was
washed twice with excess hexanes. The crude product was purified on a silica gel column using
1:1 CH2Cl2:MeOH as the eluent. Fractions were checked for purity by 31P{1H} NMR
spectroscopy, pure fractions were combined and the solvent was removed in vacuo to provide a
light brown viscous oil. Yield = 12%. 1H NMR (400 MHz, CDCl3): δ = 2.70 – 2.57 (m, 2H),
2.44 – 2.34 (m, 8H), 2.00 (t, 4J(H,H) = 2.6 Hz, 1H), 1.84 – 1.76 (m, 2H), 1.54 – 1.41 (m, 12H),
1.27 – 1.22 (m, 24H), 0.83 (t, 3J(H,H) = 6.8 Hz, 9H). 13C{1H} (100.52 MHz, CDCl3): δ = 81.9,
70.4, 31.5, 30.7 (d, 1J(P,C) = 14.1 Hz), 28.8, 22.4, 21.7 (d, 3J(P,C) = 4.0 Hz), 21.0 (d, 3J(P,C) =
4.0 Hz), 19.3 (d, 1J(P,C) = 17.1 Hz), 19.2 (d, 2J(P,C) = 46.2 Hz), 18.2 (d, 2J(C,H) = 49.2 Hz),
13.9 (s, CH3). 31P{1H} NMR (161.82 MHz, CDCl3): δ = 33.9. ATR-IR: 1460 cm-1 (m, P-CnHm),
2120 cm-1 (w, C≡C-H), 2920 cm-1 (s, CH). HRMS calculated for C29H58P [M]+: 437.4276;
Found: 437.4267.

Synthesis of Alk3P-BCP
N3-BCP (100 mg, 21 µmol, 1 equiv.) was suspended in purified water (2 mL) with stirring. The
trialkyl(1-pentynyl)phosphonium chloride (42 µmol, 2.0 equiv) as a solution in THF (0.5 mL),
and Cu(II)Cl2 (4 mg, 23 µmol, 1 equiv.) were added. A 50 mM aqueous solution of sodium
ascorbate (2 mL, 210 µmol, 10 equiv.) was added with rapid stirring and the reaction flask was
sealed. After 18 hours, the reaction mixture was dialyzed using a 10 kg/mol molecular weight
cut-off (MWCO) membrane first against 1 L of a 0.5 mM aqueous NaCl solution for 18 hours,
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then against 1 L of purified water for 12 hours twice. The sample was then lyophilized to obtain
the phosphonium-functionalized polymer as a white powder in approximately quantitative yield.
Et3P-BCP: 1H NMR (400 MHz, CDCl3): 7.70 (s, 1H), 4.50 (t, 3J(H,H) = 4.9 Hz, 2H), 4.02 (t,
3

J(H,H) = 6.6 Hz, 52H), 3.60 (m, 180H), 2.90 (t, 3J(H,H) = 6.4 Hz, 2H), 2.49 (dq, 2J(H,P) = 13.0

Hz, 3J(H,H) = 8 Hz, 6H); 2.29 (t, 3J(H,H) = 7.6 Hz, 52H), 1.66-1.56 (m, 104H), 1.40 – 1.30 (m,
52H), 1.25 (dt, 3J(H,P) = 18.0 Hz, 3J(H,H) = 7.6 Hz, 9H). 31P{1H} NMR (161.82 MHz, CDCl3):
δ = 38.7. ATR-IR: 1105 cm-1 (m, CH2-O-CH2); 1190 cm-1 (m, O-C=O); 1720 cm-1 (s, C=O);
2800 – 2900 cm-1 (m, C-H).
Bu3P-BCP: 1H NMR (400 MHz, CDCl3): δ = 7.72 (s, 1H); 4.50 (t, 3J(H,H) = 5.2 Hz, 2H), 4.03
(t, 3J(H,H) = 6.6 Hz, 52H), 3.61 (m, 180H), 2.90 (m, 2H), 2.65 (m, 2H), 2.37 (m, 8H), 2.27 (t,
3

J(H,H) = 7.6 Hz, 52H), 1.66-1.56 (m, 104H), 1.48 (m, 12H), 1.40 – 1.30 (m, 52H), 0.94 (t,

3

J(H,H) = 6.4 Hz). 31P{1H} NMR (161.82 MHz, CDCl3); δ = 33.3. ATR-IR: 1105 cm-1 (m, CH2-

O-CH2); 1190 cm-1 (m, O-C=O); 1720 cm-1 (s, C=O); 2800 – 2900 cm-1 (m, C-H).
Oct3P-BCP: 1H NMR (400 MHz, CDCl3): δ = 7.72 (s, 1H), 4.50 (t, 3J(H,H) = 5.2 Hz, 2H), 4.03
(t, 3J(H,H) = 6.6 Hz, 52H), 3.61 (m, 180H), 2.90 (m, 2H), 2.65 (m, 2H), 2.37 (m, 8H), 2.27 (t,
3

J(H,H) = 7.6 Hz, 52H), 1.66-1.56 (m, 104H), 1.48 (m, 12H), 1.40 – 1.30 (m, 52H); 0.94 (t,

3

J(H,H) = 6.4 Hz, 20H). 31P{1H} NMR (161.82 MHz, CDCl3); δ = 33.3. ATR-IR: 1105 cm-1 (m,

CH2-O-CH2); 1190 cm-1 (m, O-C=O); 1720 cm-1 (s, C=O); 2800 – 2900 cm-1 (m, C-H).

Self-assembly of block copolymers
Copolymer (5 mg) was dissolved in glass distilled THF (0.5 mL) that had been passed through a
0.22 μm polytetrafluoroethylene filter. The copolymer solution was then added to rapidly stirring
purified water (2 mL) that had been passed through an Acrodisc® Syringe Filter (0.45 µm

9

Supor® Membrane) (Pall Life Sciences). The resulting suspension was placed in a 30 °C sand
bath overnight to evaporate the THF.

Transmission electron microscopy (TEM)
TEM images were obtained using a Philips CM 10 Transmission Electron Microscope. Selfassembly samples were loaded onto Formvar-coated copper grids by placing the grid on a clean
filter paper and dropping 10 µL of a 0.5 – 1.0 mg/mL solution onto the grid, and repeating after
30 seconds. The grid was allowed to dry overnight on the filter paper and was imaged the next
day. The Alk3P-BCP nanocarriers were stained by adding 100 μL of a 1 wt% aqueous auric acid
solution to the stock TEM solution and allowing it to stir for one hour to exchange chloride
anions with aurate. The sample was then loaded onto the grid as described above.

Determination of the minimum bactericidal concentration (MBC)
The bacteria used were E. coli (ATCC 29425) and S. aureus (ATCC 6538). After inoculation of
10 mL of 0.3 mM pH 7.4 phosphate buffer, the bacteria were cultured overnight in an incubatorshaker at 37 °C. They were then pelletized by centrifugation and the broth was decanted. 10 mL
of phosphate solution was then used to resuspend the pellet. The bacteria were again pelletized
by centrifugation. This process of resuspension and centrifugation was repeated twice more. For
S. aureus, a suspension with an optical density of 0.3 at 600 nm, corresponding to 107 CFU/mL
was prepared. For E. coli, a suspension with an optical density of 0.2 at 600 nm, corresponding
to 108 CFU/mL was prepared. These stock solutions were then diluted to ~2 x 105 CFU/mL.
Samples for testing were prepared at the highest concentration for testing in 0.3 mM pH
7.4 phosphate buffer and serial two-fold dilutions were performed to achieve lower
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concentrations. All molecules and assemblies were sterilized by irradiation with UV light in a
UV light cabinet for 30 minutes prior to testing. Tests were performed in 96 well plates. Sample
wells contained 100 μL of the sample material in phosphate buffer and 100 μL of the bacterial
suspension at 105 CFU/mL. Control wells contained 100 μL of phosphate buffer and 100 μL of
the bacterial suspension at 105 CFU/mL. The phosphate buffer was also tested for sterility.
Samples and controls were measured in triplicate. The wells were mixed for 4 hours at ambient
temperature using a Tecan infinite M1000 Pro (Tecan Trading AG, Switzerland) plate reader.
The suspensions were then diluted by adding 100 μL of the well contents into 9.9 mL of
phosphate buffer to give a resulting bacterial concentration of approximately 103 CFU/mL. 100
μL of this suspension was then pour plated in nutrient agar and incubated overnight at 37 °C. The
nutrient agar was prepared by dissolving 25 g of LB broth (Miller’s modification) (Alfa Aesar,
Reston, United States) and 15 g of Agar Powder (C12H18O9)x (Alfa Aesar, Reston, United States)
in 1 L of hot water (85°C). The following day the bacterial colonies were counted. The MBC
was determined as the concentration where no bacterial colonies were observed (>99% reduction
in viability, based on 102 CFUs plated). A summary of the concentrations tested and their
corresponding results are includes in Tables S1 and S2.

Hemolysis assay
The hemolytic activity of the nanocarriers was determined using sterile defibrinated sheep’s
blood (Cedarlane Labs, Burlington Ontario, Canada). The blood was pelletized by centrifuging 1
mL of the blood and washing the pellet four times with 0.9 % saline. The pellet was resuspended
in 1 mL of a phosphate buffered saline (PBS) consisting of 0.32 mM NaH2PO4 and 140.40 mM
NaCl maintained at a pH of 7.4 to create the red blood cell (RBC) suspension. A concentrated
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solution of the micelles was diluted with 750 μL of the PBS to the highest concentration for the
assay. The micelle solutions were diluted two-fold serially with PBS to achieve the desired
concentrations. To the micelle solutions 25 µL of the RBC suspension was added. A negative
control of 25 µL of the RBC suspension in 1000 µL of the PBS and a positive control of 25 µL of
the RBC suspension in 1000 µL purified water. Nanocarrier background controls were made
consisting of the same concentration of the nanocarrier in PBS to eliminate absorbance or
scattering contributions from the nanocarriers themselves. The samples were incubated at room
temperature for 2 hours and afterward the samples were centrifuged to re-pelletize the blood
cells. 200 µL of the supernatant of each sample and control were placed into wells in a 96 well
plate and the absorbance (A) at 540 nm was measured. The percent hemolysis was determined
with the following equation:
Percent Hemolysis =

Asample - Amicelles - Anegative control
×100%
Apositive control - Anegative control

Tetracycline encapsulation
500 μL of a solution of tetracycline (0.5 mg/mL in CHCl3) was used to dissolve either MeOBCP or Bu3P-BCP (5 mg). With rapid stirring 2 mL of purified water was added and stirring
was continued overnight at 30 °C. The sample was covered with aluminum foil to allow
evaporation of CHCl3 while at the same time preventing exposure to ambient light. The resulting
suspension was then introduced into a MicrosepTM Advance Centrifugal Device with a 10 kg/mol
MWCO (Pall Life Sciences) and the solvent was reduced to 1/5 its initial volume. The
concentrated suspension was diluted to 2 mL of purified water, and centrifugation was performed
again. The filtrate was combined and the concentration of tetracycline in the filtrate was
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measured by UV-visible spectroscopy (e = 14,075 M-1cm-1 in water at 363 nm) in order to
determine the encapsulation efficiency (EE) of tetracycline as:
EE =

Mass of Drug in Particles
×100%
Mass of Drug Added

The drug loading content (DLC) of the assemblies could then be calculated as:
DLC=

Mass of Drug in Particles
×100 %
Mass of Loaded Particles

Tetracycline release study
Assemblies containing encapsulated tetracycline were prepared as described above except that
0.3 mM, pH 7.2 phosphate buffer was used. A volume of 2 mL each of tetracycline-loaded
MeO-BCP or Bu3P-BCP micelles was then placed on a wrist-action shaker. At measurement
time points, centrifugal ultrafiltration was performed as described above to separate released
tetracycline from the suspension and the concentrated suspension was diluted again to 2 mL with
the phosphate buffer. The absorbance of the filtrate was measured and the concentration of
tetracycline in the filtrate was determined based on an e = 14,075 M-1cm-1 in the same buffer at
363 nm.

Results and Discussion
Synthesis of PEO-b-PCL copolymers
PEO-b-PCL copolymers were selected because of their established biocompatibility and low
toxicity in drug delivery applications.39 An azide terminal group on the PEO was selected for the
conjugation of the phosphonium moiety via a copper-assisted azide-alkyne cycloaddition
(CuAAC). Methoxy- and azide-terminated PEO-b-PCL copolymers, MeO-BCP and N3-BCP
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respectively, were synthesized according to our previously reported procedure.38 MeO-PEO or
N3-PEO were used as macroinitiators to polymerize caprolactone in toluene using
methanesulfonic acid (MSA) as a catalyst (Scheme 1).38 This method yields copolymers with
very low molar mass dispersity (Ð). Low Ð is important for good control over the morphology of
the self-assemblies.40 From previous research it is known that a mass ratio of PCL:PEO of 1.3:1
yields micellar nanocarriers.41 Therefore, using a PEO macroinitiator of ~2000 g/mol, a degree
of polymerization (DP) of ~24 caprolactone repeat units was targeted. The resulting block
copolymers were characterized by NMR spectroscopy and SEC. 1H NMR spectroscopy
confirmed that the DPs were ~24 for each of MeO-BCP and N3-BCP, corresponding to an Mn of
~4700 g/mol (Figure S1-S2). By SEC relative to PEO standards, MeO-BCP had a number
average molar mass (Mn) of 5750 g/mol and Ð of 1.11, while N3-BCP had an Mn of 5950 g/mol
and Ð of 1.12 (Figure S3). The differences in Mn of these copolymers measured by SEC likely
arose from their different terminal groups.

Scheme 1. Synthesis of MeO-BCP and N3-BCP.
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Synthesis of alkyne-functionalized phosphonium salts
Alkyne-functionalized phosphonium centres were required for conjugation to N3-BCP. The
lengths of the alkyl chains on phosphonium and ammonium salts are known to affect the
antibacterial activity of the small molecules,32 so it was desirable to explore this in the context of
phosphonium-functionalized polymer assemblies. Initial attempts to prepare the alkynefunctionalized phosphonium salts by reaction of trialkylphosphines with propargyl bromide
resulted in complex and inseparable product mixtures. This is due to side reactivity of the
phosphonium salt with the unreacted phosphine.42 While addition of hydrobromic acid to the
reaction reduced the number of products, isolation of the desired product remained elusive. On
the other hand, use of 5-chloro-1-pentyne led to the conversion of triethylphosphine and tri-nbutylphosphine into single products Et3P-yne and Bu3P-yne, respectively (Scheme 2). The
synthesis of Oct3P-yne yielded a mixture of products and silica gel column chromatography was
used for purification. This was attributed to the extended heating time required to convert the
starting material into product as this phosphine is more sterically hindered. In each case, the pure
product was characterized by multinuclear magnetic resonance spectroscopy and high resolution
mass spectrometry. The products showed characteristic peaks corresponding to both the alkyne
and alkyl chains around the phosphonium cation (Figure 2).
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Scheme 2. Synthesis of the phosphonium salts and the phosphonium capped polymers.
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Figure 2. 1H NMR spectra (CDCl3, 400 MHz) of the phosphonium salts with selected peaks
labeled.

Conjugation of the phosphonium cations to the block copolymers
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Attachment of the phosphonium salts to N3-BCP was achieved using CuAAC in 4:1 H2O:THF
with CuCl2 and sodium ascorbate to afford Et3P-BCP, Bu3P-BCP, and Oct3P-BCP (Scheme 2).
Due to the onwards use of the polymer in anti-bacterial testing it was imperative that any residual
copper be removed from the functionalized materials. The reaction mixtures were therefore
dialyzed against large volumes of 0.5 M NaCl solution, followed by water. The dialysis against
aqueous NaCl was important to ensure that the phosphonium counterion remained chloride as
there are reports in the literature that ascorbate may show antibacterial activity, thus we needed
to preclude the chance of anion exchange.43 As shown in Figure 3 and S9-S10, IR spectra of the
initial N3-BCP showed strong azide stretches at 2100 cm-1, whereas this peak was no longer
detectable beyond the background noise for the conjugated phosphonium products. Integration of
the 1H NMR signals corresponding to the methyl protons on the phosphonium groups relative to
the terminal methylene group of the PEO block adjacent to the first repeat unit of the PCL block
were consistent with complete conversion of the azides (Figure S11-S13). Peaks characteristic of
the proton on the triazole ring were also observed in the 1H NMR spectra of the phosphonium
functionalized polymers.

2000 2200

1500

2000
2500
3000
-1
Wavenumber (cm )
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Figure 3. ATR-IR spectra of the starting N3-BCP (blue spectrum) and Bu3P-BCP (orange
spectrum) showing the disappearance of the azide stretch following the CuAAC reaction.

Micelle preparation and characterization
The micelles were prepared from MeO-BCP, Et3P-BCP, Bu3P-BCP, and Oct3P-BCP by
nanoprecipitation of a polymer solution in THF into water, which is a selective solvent for the
PEO block of the copolymers. The rapid decrease in solubility of the PCL block in the solvent
mixture causes the polymers to precipitate into nano-sized cores surrounded by PEO. Figures 4
A-D show representative TEM images of the resulting assemblies. Assemblies prepared from the
phosphonium cation-capped polymers were stained using auric acid (Figure 4B-D). In this case,
the aurate can undergo anion exchange to bind to the positively charged phosphonium ion.44 In
each case, solid spherical particles were observed. The sub-50 nm diameters of the MeO-BCP,
Et3P-BCP, and Bu3P-BCP assemblies suggests that they were largely true micellar structures,
whereas some larger 50 – 100 nm assemblies were observed for Oct3P-BCP, suggesting that
some compound micelles or aggregates of micelles were also present. The Oct3P-yne is not
soluble in water and so installation of this hydrophobic end group on the hydrophilic block may
cause this aggregation.
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Figure 4. A – D) TEM micrographs of the assemblies prepared by nanoprecipitation (scale bar
represents 100 nm): A) MeO-BCP micelles, B) Et3P-BCP micelles, C) Bu3P-BCP micelles, D)
Oct3P-BCP assemblies. All Alk3P-BCP samples (B-D) were stained with auric acid. E) Volume
distributions of the assembly diameters measured by DLS.

As shown in Figure 4E and Table 1, the hydrodynamic diameters measured by dynamic
light scattering (DLS) were in good agreement with the sizes observed by TEM. MeO-BCP
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micelles had a Z-average diameter of ~30 nm, while Et3P-BCP, and Bu3P-BCP micelles had
similar Z-average diameters of 40 – 45 nm. The larger diameters of these phosphoniumfunctionalized micelles relative to the MeO-BCP micelles may result from repulsive
electrostatic interactions between the peripheral phosphoniums. Oct3P-BCP assemblies had a
larger Z-average diameter of 59 nm due to the presence of compound micelles or aggregates as
noted above. ζ-potentials of the micelles were also measured. MeO-BCP micelles had a ζpotential of -23 mV. This is typical for assemblies with PEO coronas.45 On the other hand, all of
the phosphonium-functionalized micelles had positive ζ-potentials and these ranged from 19 to
30 mV. This confirms that the phosphonium cations reside on the surface of the micelles.
Interestingly, the value of the ζ-potential increased with the length of the alkyl chain on the
phosphonium center. This was somewhat unexpected as the more hydrophobic phosphonium
cations could be buried within the PEO corona. However, the results reveal that this may not be
the case and the cause of the observed trend in not clear at this time.

Table 1. Hydrodynamic diameters and ζ-potentials measured for the polymer assemblies by
dynamic light scattering.
Z-average

Polydispersity index

ζ-potential

diameter (nm)

(PDI)

(mV)

MeO-BCP micelles

29.5 ± 0.8

0.122 ± 0.027

-23.2 ± 5.2

Et3P-BCP micelles

45.0 ± 2.5

0.072 ± 0.003

19.0 ± 2.4

Bu3P-BCP micelles

39.6 ± 3.7

0.213 ± 0.025

26.8 ± 7.7

Oct3P-BCP assemblies

58.9 ± 2.8

0.110 ± 0.020

29.7 ± 0.5
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Antibacterial properties of phosphonium-functionalized assemblies
The antibacterial efficacies of the phosphonium-functionalized micelles and their corresponding
small molecule phosphonium salts were evaluated by measuring their minimum bactericidal
concentrations (MBC). The MBC is the concentration required to kill 99% of bacteria in the
assay. This assay involved inoculating varying concentrations of the assemblies or small
molecules in pH 7.4 phosphate buffer with a bacterial suspension containing 105 colony forming
units (CFU)/mL of either Gram-negative E. coli (ATCC 29425) or Gram-positive S. aureus
(ATCC 6538). The inoculated samples were incubated at 37 °C for 4 hours, then the resulting
suspensions were plated on agar, incubated overnight and then the bacterial colonies were
counted. The percent reduction, and thus MBC, was calculated by comparing the number of
colonies counted after incubation with the sample compared to those of bacteria exposed to only
phosphate buffer with no polymer or small molecule added.
As shown in Table 2, the small molecule phosphonium cations had relatively high MBC
values against both E. coli and S. aureus. It was not possible to test Oct3P-yne due to its poor
aqueous solubility, but Et3P-yne had a MBC greater than 45 mM, the highest concentration
tested, against S. aureus than E. coli. Bu3P-yne was more active, with MBC values of 4.1 mM
and 33 mM for S. aureus than E. coli, respectively. MeO-BCP micelles were also studied and
the MBC was found to be greater than 1.1 mM in terms of polymer chain concentration for both
strains of bacteria, the highest concentration tested. Thus, the block copolymers themselves are
not antibacterial. On the other hand, the phosphonium-functionalized assemblies all had much
lower MBCs than the small molecules, demonstrating the importance of having a multivalent
display of cations. Interestingly there was no observed difference in MBC between the Et3PBCP micelles and Bu3P-BCP micelles with S. aureus (0.13 mM for both systems), but there was
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with E. coli (0.26 mM and 0.13 mM, respectively). The Oct3P-BCP assemblies had the greatest
activity against S. aureus with an MBC of 0.031 mM, while they had the highest MBC of the
phosphonium-functionalized assemblies against E. coli at 0.49 mM.
Table 2. MBC values for the phosphonium salts and phosphonium-functionalized assemblies
against S. aureus and E. coli. For the block copolymers, the concentrations correspond to the
concentrations of polymer chains, and thus the concentration of the terminal phosphonium
groups.
Compound

MBC against

MBC against

S. aureus

E. coli

(mM)

(mM)

Et3P-yne

> 45

> 45

Bu3P-yne

4.1

32.8

MeO-BCP

> 1.1

> 1.1

0.13

0.26

0.13

0.13

0.031

0.49

micelles
Et3P-BCP
micelles
Bu3P-BCP
micelles
Oct3P-BCP
micelles

With the exception of Bu3P-BCP micelles, higher MBC values were found for E. coli.
The lower efficacy against E. coli was expected based on previous research, and can likely be
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attributed to differences in the cell wall structures of Gram-positive and Gram-negative
bacteria.46 Gram-positive bacteria such as S. aureus have a plasma membrane surrounded by a
periplasmic space and a peptidoglycan layer, whereas Gram-negative bacteria such as E. coli
have an additional outer membrane surrounding the peptidoglycan layer. The mode of action of
monocationic and polycationic biocides is generally accepted to include the following processes:
1) Biocide adsorption to the cell surface, 2) biocide diffusion through the cell wall, 3) adsorption
to the cytoplasmic membrane, 4) cytoplasmic membrane disruption, and 5) loss of cytoplasmic
components, resulting in cell death.31 Gram-negative bacteria have an additional barrier through
which the biocide must diffuse, and disrupt, which may explain why higher concentrations of
micelles were generally required to kill E. coli.
It was also noted that different trends with respect to alkyl chain length were observed for
the different strains of bacteria as Oct3P-BCP micelles had the lowest MBC for S. aureus,
whereas Bu3P-BCP micelles had the lowest MBC for E. coli. While phosphonium groups with
longer alkyl chains have been previously demonstrated to show greater antibacterial activity in
general34 there is also data to suggest that the relationship between alkyl chain length and
antibacterial efficacy is not linear and in some cases lower activity has been observed with
increased alkyl chain length.47 As hydrophilic cationic groups promote attachment to bacterial
membrane and hydrophobic alkyl chains insert into membranes to disrupt them, the
hydrophilicity and hydrophobicity must be balanced to match the requirements of the different
bacterial membranes. 48 It is also possible that the larger size of the Oct3P-BCP assemblies plays
a role. The larger size of the individual assemblies results in fewer particles for a given
polymer/phosphonium concentration and thus fewer assemblies and less surface area to interact
with the bacteria.49 In comparing the small molecule cationic biocides with polycationic
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biocides, the small molecules typically have higher rates of diffusion through the cell wall, while
the multivalent nature of polycationic biocides increases the adsorption to the cell surface and the
cytoplasmic membrane, often leading to increased rates and occurrences of cytoplasmic
membrane disruption.31
The phosphonium-functionalized assemblies can also be compared with other
antibacterial polymer assemblies. For example, Du and co-workers demonstrated the preparation
of silver nanoparticle-decorated micelles and vesicles with antibacterial activity.21 These
assemblies had a low MBC of 8.69 x 10-2 mM of Ag. However, it is unclear whether the activity
of the system arose from nano-silver associated with the micelles or dissociated Ag+ ions
released into solution that were not associated with the micellar corona.21 The mechanism of
bacterial killing by nano-silver, while controversial,50 is also different and is thought to involve
the inactivation of the bacterial DNA and ribosomes by silver ions.51,52 Later, the same group
reported the preparation of antibacterial nanoassemblies composed of poly[2-(2methoxyethoxy)ethyl methacrylate]20-block-poly[2-(tert-butylaminoethyl) methacrylate]20.26 The
polyamine block ionizes in solution to give positively charged particles. Vesicles prepared from
the above polymer were reported to have MBC values of 0.63 mM of amine against both E. coli
and S. aureus.26 Later, multicompartment polymer vesicles prepared from the same polymers
were reported to have improved antibacterial efficacy with MBC values of 0.1 mg/mL or 1.27 x
10-2 mM of amine, a value lower than their measured minimum inhibitory concentration (MIC)
values for the same material.27 As the MIC corresponds to the concentration required to inhibit
bacterial growth but not necessary kill the bacteria, MIC values are not generally expected to be
higher than MBC values. However, this discrepancy may be due to differences in the testing
methods. Du and coworkers also reported that low MIC values in the μM range could be
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achieved against E. coli and S. aureus using polypeptides as the hydrophilic block of a vesicle
forming polymeric amphiphile.53

Hemolysis of red blood cells
A challenge often encountered with membrane-active antibacterial agents is that in addition to
lysing bacterial cell membranes, they can also lyse the membranes of red blood cells, resulting in
non-specific toxicity. Therefore, to evaluate the potential of the phosphonium-functionalized
micelles to lyse red blood cells, a hemolysis assay was performed. Briefly, following a
previously reported procedure,54 red blood cells were obtained from defibrinated sheep blood
and were incubated with MeO-BCP, Et3P-BCP, Bu3P-BCP, Oct3P-BCP micelles in PBS for 2
hours. As a positive control, red blood cells were suspended in deionized water, resulting in the
immediate lysis of the cells. The absorbance of the supernatant at 540 nm after pelletization of
the intact blood cells was measured. As shown in Figure 5, only 0.53 mM of Et3P-BCP micelles
exhibited any hemolytic activity, with 7% hemolysis observed. Interestingly, this particular
system was the least active of the 3 systems against both strains of bacteria, so this result was
unexpected. While there is not a complete understanding of all the factors influencing selectivity
for eukaryotic and prokaryotic membranes,46 it is likely that the particular hydrophilichydrophobic balance of the Et3P-BCP micelles results in its higher activity against red blood cell
membranes.55 Nevertheless, the overall results suggest that the phosphonium-functionalized
micelles have good potential to selectively kill bacteria. While further studies would be required
to elucidate the in vitro and in vivo toxicity, previous studies have shown that phosphonium
compounds can exhibit low in vitro,36,56 and in vivo56 toxicity.
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Figure 5. Hemolysis of red blood cells from defribinated sheep blood. 0% hemolysis
corresponds to the control of red blood cells in PBS while 100% hemolysis corresponds to the
positive control of red blood cells in purified water.

Encapsulation and release of tetracycline
The antibacterial efficacy of the phosphonium-functionalized assemblies can potentially be
enhanced through encapsulation of a small molecule antibiotic that acts through a mechanism
other than membrane disruption, thereby targeting multiple different stages of the infection
process. Such an approach has not been explored in the context of antibacterial polymer
assemblies to the best of our knowledge. Tetracycline (Figure 6) was chosen as the antibiotic as
it is widely used and is hydrophobic, resulting in low aqueous solubility and the possibility to
encapsulate it in the hydrophobic PCL cores of the micelles. Tetracycline acts by binding to the
bacterial ribosome and preventing the production of new proteins.57 It was encapsulated in the
micelles through co-dissolution with the polymer in CHCl3, followed by the addition of water
with rapid stirring and heating at 30 °C overnight to evaporate the CHCl3. Unencapsulated drug
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was then removed by centrifugal ultrafiltration (Figure S14). This procedure was performed for
both MeO-BCP and Bu3P-BCP in order to determine the effect of the phosphonium moieties on
the drug loading and release. This afforded assemblies with diameters of 65 ± 5 nm for MeOBCP as measured by DLS (Figure S15). The amount of drug loaded into the assemblies was
determined as the difference between the drug added during assembly and the unencapsulated
drug removed by ultrafiltration, which was determined by UV-vis spectroscopy. The EE and
DLC were determined to be 31 ± 7 % and 2.0 ± 0.2 % for MeO-BCP and, 42 ± 3 % and 3.1 ±
0.3 % for Bu3P-BCP respectively. The higher EE and DLC observed in the Bu3P-BCP system
may result from ionic interactions between the anionic tetracycline and the cationic phosphonium
ions on the micelles.

Figure 6. Release profiles of tetracycline from MeO-BCP micelles and Bu3P-BCP micelles.
Inset: tetracycline structure

The release rate of tetracycline from the MeO-BCP and Bu3P-BCP micelles was then
studied by incubating the drug-loaded micelles at 37 °C in pH 7.2 phosphate buffer. At each time
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point, centrifugal ultrafiltration was used to separate the micelles from the released drug and the
concentration of the released drug was measured. As shown in Figure 6, all of the encapsulated
tetracycline was released from the MeO-BCP micelles in ~5 hours. The release of tetracycline
was somewhat slower from the Bu3P-BCP micelles, with ~70% of the drug being released over
the first 5 h and 100% release over 24 h. The differences in release rates between the two
systems is likely due to the presence of the phosphonium end cap. Upon release from the
hydrophobic micelle core into the phosphate buffer, tetracycline’s vinylogous carboxylic acid
may become deprotonated and undergo ionic interactions with the phosphonium cations on the
surfaces of the micelle, thereby slowing its release.
Antibacterial assays with E. coli were performed to examine the added effect of the
tetracycline in the micelle core. It was found that at the tetracycline loadings described above,
the activity of the Bu3P-BCP micelles was dominated by the phosphonium groups and the same
MBC value was determined. No activity was observed for tetracycline-loaded MeO-BCP
micelles over a 4 hour incubation at a concentration of 0.26 mM of polymer. This can be
attributed to the bacteriostatic effects of tetracycline. On the time scale of the experiment, the
tetracycline would not kill bacteria but instead just inhibit its ability to produce new proteins.58
Thus, these experiments were not able to reveal an additive or synergistic effect of the drug and
phosphonium on the bacteria. However, this does not preclude the possibility of observing one in
vivo where the released drug could exhibit significantly different biodistribution than the
assemblies and may reach sites not accessible to the polymer assemblies. Further studies will be
needed to investigate this possibility.

Conclusions

28

In conclusion, this study demonstrated the synthesis and self-assembly of three new
phosphonium-functionalized PEO-b-PCL copolymers with varying alkyl chain lengths on the
phosphonium. Et3P-BCP, Bu3P-BCP, and the control MeO-BCP self-assembled into micelles
with diameters less than 50 nm, while Oct3P-BCP formed larger micelles or aggregates. All of
the phosphonium-functionalized assemblies had positive z-potentials, whereas the MeO-BCP
micelles had a negative z-potentials. Despite relatively low loadings of the antibacterial
component (only a single phosphonium unit per polymer chain), sub-mM MBC values were
obtained against both E. coli and S. aureus and the activities of the different systems depended
on the bacterial stain due to differences in their cell wall structures. In comparing the MBC
values for the assemblies with those of the corresponding phosphonium small molecules, the
assemblies were much more effective in killing bacteria, presumably due to their multivalent
interactions with the bacteria. The low loadings of the phosphonium groups on the assemblies
also allowed then to exhibit excellent hemolytic stability, with only the highest concentration of
Et3P-BCP micelles showing any hemolytic activity, above the MBC for both S. aureus and E.
coli. It was also demonstrated that the intrinsically antibacterial Bu3P-BCP micelles could
encapsulate and release tetracycline, providing the potential for an orthogonal mechanism of
attack against bacteria during the infection process. Future work will involve further
optimization of the system and as well as further exploration of the multifunctional capabilities
of these micelles.

Supporting information
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